Income Statement Shandong Ruifeng Chemical Co., Ltd.

Stocks

300243

CNE1000015J9

Commodity Chemicals

End-of-day quote Shenzhen S.E. 11/09/2026			5-day change	1st Jan Change
15.72 ^CNY	-2.00%		+2.34%	+50.72%

08-17	Shandong Ruifeng Chemical Co., Ltd. signed a letter of intent to acquire an unknown minority stake in Anhui Mituo New Materials Technology Co., Ltd.	CI
08-14	Anhui Mituo New Materials Technology Co., Ltd announced that it expects to receive funding from Shandong Ruifeng Chemical Co., Ltd.	CI

e9b7788488a8c7327d6eafec.V45to1qSd0BBdIscL-3swooqd9MTBI7kF2r4T340ZkU.MdgP1w_zQwg0Pd9mVt-O-t9QROp2V-OdfgDKDCkCViA5uFj7Av1HDBUbwg

Published financial data: SHANDONG RUIFENG CHEMICAL CO., LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Revenues	1.85B	1.83B	1.77B	2B	1.97B
Other Revenues, Total	6.7M	1.85M	3.83M	2.25M	3.04M
Total Revenues	1.86B	1.83B	1.78B	2B	1.97B
Cost of Goods Sold, Total	1.53B	1.52B	1.47B	1.72B	1.68B
Gross Profit	328M	307M	308M	282M	287M
Selling General & Admin Expenses, Total	168M	223M	187M	186M	204M
Provision for Bad Debts	1.08M	180K	-422K	5.18M	149K
R&D Expenses	4.31M	6.43M	14.6M	9.01M	8.57M
Other Operating Expenses	5.51M	6.65M	11.72M	4.33M	-2.63M
Other Operating Expenses, Total	179M	236M	213M	205M	210M
Operating Income	148M	71.26M	95M	77.47M	76.49M
Interest Expense, Total	-20.71M	-21.23M	-22.58M	-41.78M	-44M
Interest And Investment Income	5.39M	1.11M	4.09M	3.53M	3.8M
Net Interest Expenses	-15.31M	-20.11M	-18.49M	-38.25M	-40.2M
Income (Loss) On Equity Invest.	-	-	-	-433K	-276K
Currency Exchange Gains (Loss)	-1.61M	6.99M	3.15M	5.37M	-497K
Other Non Operating Income (Expenses)	-3.18M	-3.57M	526K	-1.89M	-1.36M
EBT, Excl. Unusual Items	128M	54.56M	80.18M	42.27M	34.16M
Gain (Loss) On Sale Of Assets	-54.57K	193K	194K	19.52K	-
Asset Writedown	-	-	-3.2M	-14.48M	-
Other Unusual Items	-21.67M	17.22M	12.81M	4.47M	-863K
EBT, Incl. Unusual Items	107M	71.98M	89.99M	32.27M	33.29M
Income Tax Expense	15.49M	10.84M	4.71M	10.56M	3.53M
Earnings From Continuing Operations	91.05M	61.14M	85.28M	21.72M	29.76M
Net Income to Company	91.05M	61.14M	85.28M	21.72M	29.76M
Minority Interest	1.82M	-	18.05K	357K	569K
Net Income - (IS)	92.87M	61.14M	85.29M	22.08M	30.33M
Net Income to Common Incl Extra Items	92.87M	61.14M	85.29M	22.08M	30.33M
Net Income to Common Excl. Extra Items	92.87M	61.14M	85.29M	22.08M	30.33M
Per Share Items
Net EPS - Basic	0.4	0.26	0.36	0.1	0.13
Basic EPS - Continuing Operations	0.4	0.26	0.36	0.1	0.13
Basic Weighted Average Shares Outstanding	232M	235M	237M	221M	233M
Net EPS - Diluted	0.39	0.26	0.36	0.1	0.13
Diluted EPS - Continuing Operations	0.39	0.26	0.36	0.1	0.13
Diluted Weighted Average Shares Outstanding	238M	235M	237M	221M	233M
Normalized Basic EPS	0.35	0.15	0.21	0.12	0.09
Normalized Diluted EPS	0.34	0.15	0.21	0.12	0.09
Dividend Per Share	0.12	-	0.1	0.05	0.1
Payout Ratio	43.06	60.69	9.96	174.35	101.79
Supplemental Items
EBITDA	189M	125M	153M	170M	172M
EBITA	151M	73.7M	97.8M	80.27M	79.42M
EBIT	148M	71.26M	95M	77.47M	76.49M
EBITDAR	191M	127M	-	173M	174M
Total Revenues (As Reported)	1.86B	1.83B	1.78B	2B	1.97B
Effective Tax Rate - (Ratio)	14.54	15.06	5.24	32.7	10.6
Total Current Taxes	16.62M	14.65M	2.59M	16.55M	18.4M
Total Deferred Taxes	-1.13M	-3.81M	2.12M	-6M	-14.87M
Normalized Net Income	81.98M	34.1M	50.13M	26.77M	21.92M
Interest Capitalized	-	17.62M	18.77M	-	-
Interest on Long-Term Debt	5.19M	8.89K	41.05M	-	-
Supplemental Operating Expense Items
Marketing Expenses	-	-	-	-	91.01M
Selling and Marketing Expenses	104M	129M	113M	93.12M	114M
General and Administrative Expenses	62.64M	91.4M	74.45M	90.12M	88.01M
Research And Development Expense From Footnotes	93.41M	99.83M	101M	109M	8.97M
Net Rental Expense, Total	1.69M	2.04M	-	2.8M	2.54M
Imputed Operating Lease Interest Expense	599K	954K	-	1.09M	939K
Imputed Operating Lease Depreciation	1.09M	1.09M	-	1.71M	1.6M
Maintenance & Repair Expenses, Total	14.58M	918K	13.39M	10.74M	10.35M
Stock-Based Comp., G&A Exp. (Total)	2.24M	7.3M	-3.3M	-	-
Stock-Based Comp., Other (Total)	-	-	-	-	-
Total Stock-Based Compensation	2.24M	7.3M	-3.3M	-	-

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Assets
Cash And Equivalents	233M	186M	306M	280M	359M
Trading Asset Securities, Total	-	-	-	-	-
Total Cash And Short Term Investments	233M	186M	306M	280M	359M
Accounts Receivable, Total	452M	509M	526M	615M	669M
Other Receivables	12.3M	16.44M	811K	1.66M	883K
Total Receivables	464M	526M	527M	616M	670M
Inventory	119M	203M	217M	321M	272M
Prepaid Expenses	424K	-	-	-	-
Other Current Assets, Total	58.14M	32.62M	55.89M	36.99M	38.88M
Total Current Assets	875M	947M	1.11B	1.25B	1.34B
Gross Property Plant And Equipment	901M	1.11B	1.23B	1.28B	1.31B
Accumulated Depreciation	-254M	-302M	-332M	-422M	-514M
Net Property Plant And Equipment	647M	811M	901M	861M	798M
Long-term Investments	662K	640K	5.14M	4.07M	3.79M
Goodwill	-	-	-	-	-
Other Intangibles, Total	75.69M	99.42M	96.62M	93.82M	98.26M
Deferred Tax Assets Long-Term	17.18M	20.99M	18.87M	24.96M	27.59M
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	72.96M	61.51M	47.04M	46.62M	43.65M
Total Assets	1.69B	1.94B	2.17B	2.29B	2.31B
Liabilities
Accounts Payable, Total	133M	138M	141M	121M	128M
Accrued Expenses, Total	59.57M	16.85M	74.4M	59.51M	34.36M
Short-term Borrowings	177M	315M	323M	413M	452M
Current Portion of Long-Term Debt	8.8M	69M	40.72M	78.17M	94M
Current Portion of Leases	-	-	256K	265K	-
Current Income Taxes Payable	1.35M	6.57M	93.8K	8.42M	9.32M
Unearned Revenue Current, Total	10.41M	11.62M	10.54M	9.73M	10.36M
Other Current Liabilities	9.56M	66.2M	10.09M	10.3M	11.83M
Total Current Liabilities	400M	623M	600M	701M	740M
Long-Term Debt	386M	375M	425M	442M	423M
Long-Term Leases	-	-	265K	-	-
Unearned Revenue Non Current	8.32M	8.67M	7.42M	5.37M	4.49M
Other Non Current Liabilities	-	-	-	-	724K
Total Liabilities	794M	1.01B	1.03B	1.15B	1.17B
Common Stock, Total	232M	232M	250M	250M	250M
Additional Paid In Capital	67.54M	75.76M	178M	178M	178M
Retained Earnings	519M	552M	638M	635M	653M
Treasury Stock	-	-	-	-	-
Comprehensive Income and Other	75.07M	75.05M	75.03M	74.51M	62.2M
Total Common Equity	894M	935M	1.14B	1.14B	1.14B
Minority Interest	-	-	-18.05K	-356K	-925K
Total Equity	894M	935M	1.14B	1.14B	1.14B
Total Liabilities And Equity	1.69B	1.94B	2.17B	2.29B	2.31B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	232M	232M	250M	250M	251M
ECS Total Common Shares Outstanding	232M	232M	250M	250M	250M
Book Value / Share	3.85	4.03	4.56	4.54	4.56
Tangible Book Value	818M	836M	1.04B	1.04B	1.04B
Tangible Book Value Per Share	3.52	3.6	4.17	4.17	4.17
Total Debt	572M	758M	789M	933M	969M
Net Debt	338M	572M	484M	653M	611M
Debt Equivalent Oper. Leases	13.53M	16.32M	-	22.41M	20.3M
Minority Interest, Total (Incl. Fin. Div)	-	-	-18.05K	-356K	-925K
Equity Method Investments, Total	-	-	4.5M	4.07M	3.79M
Account Code - Inventory Valuation	5	6	6	6	6
Inventories - Raw Materials, Total	25.59M	43.78M	47.31M	44.2M	51.46M
Inventories - Finished Goods, Total	93.02M	159M	172M	283M	225M
Buildings, Total	326M	382M	478M	493M	496M
Machinery, Total	327M	364M	565M	600M	626M
Full Time Employees	880	930	905	918	973
Accumulated Allowance for Doubtful Accounts (Supple)	32.57M	31.32M	30.9M	36.02M	36.17M

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Net Income	92.87M	61.14M	85.29M	22.08M	30.33M
Depreciation & Amortization - CF	38.47M	50.83M	55.21M	90.29M	92.47M
Amortization of Goodwill and Intangible Assets - (CF)	2.2M	2.44M	2.8M	2.8M	2.94M
Depreciation & Amortization, Total	40.67M	53.27M	58.01M	93.09M	95.4M
Amortization of Deferred Charges, Total - (CF)	750K	4.78K	703	-	-
(Gain) Loss From Sale Of Asset	54.57K	-193K	-194K	-19.52K	-
(Gain) Loss on Sale of Investments - (CF)	-3.86M	-	-21.07K	433K	276K
Asset Writedown & Restructuring Costs	5.83M	7.84M	2.33M	14.48M	488K
Provision and Write-off of Bad Debts	1.08M	180K	-422K	5.18M	149K
Other Operating Activities, Total	17.61M	16.27M	18.91M	37.59M	39.59M
Change In Accounts Receivable	-33.06M	-91.05M	-45.85M	-98.43M	-73.88M
Change In Inventories	18.92M	-76.6M	-16.71M	-107M	49.07M
Change In Accounts Payable	-28.59M	24.33M	-7.28M	15.98M	6.48M
Change In Deferred Taxes	-1.13M	-3.81M	2.12M	-6.09M	-14.87M
Cash from Operations	111M	-8.62M	96.2M	-23.2M	133M
Capital Expenditure	-272M	-176M	-153M	-69.3M	-33.67M
Sale of Property, Plant, and Equipment	6.28K	875K	-	130K	-
Cash Acquisitions	-	-	-	-	-
Investment in Marketable and Equity Securities, Total	38.72M	13.7M	-4.48M	-	-
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-233M	-162M	-158M	-69.17M	-33.67M
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	369M	429M	498M	688M	894M
Total Debt Issued	369M	429M	498M	688M	894M
Short Term Debt Repaid, Total	-	-	-	-	-
Long-Term Debt Repaid, Total	-445M	-250M	-330M	-491M	-713M
Total Debt Repaid	-445M	-250M	-330M	-491M	-713M
Issuance of Common Stock	340M	-	124M	-	-
Common Dividends Paid	-39.99M	-37.11M	-8.5M	-38.49M	-30.88M
Common & Preferred Stock Dividends Paid	-39.99M	-37.11M	-8.5M	-38.49M	-30.88M
Other Financing Activities, Total	-5.95M	-91.97M	-99.64M	-170M	-198M
Cash from Financing	218M	49.72M	183M	-11.84M	-47.77M
Foreign Exchange Rate Adjustments	-1.02M	1.8M	1.58M	4.57M	1.29M
Net Change in Cash	95.37M	-119M	123M	-99.64M	52.89M
Supplemental Items
Cash Income Tax Paid (Refund)	12.1M	-5.83M	28.86M	-17.54M	9.28M
Levered Free Cash Flow	-160M	-180M	-94.6M	-155M	60.1M
Unlevered Free Cash Flow	-147M	-166M	-80.49M	-129M	87.6M
Change In Net Working Capital	12.22M	95.14M	41.28M	202M	21.94M
Net Debt Issued / Repaid	-75.95M	179M	168M	197M	181M

Fiscal Period: December	2021 (CNY)	2022 (CNY)	2023 (CNY)	2024 (CNY)	2025 (CNY)
Profitability
Return on Assets	6.17	2.45	2.89	2.17	2.09
Return on Total Capital	7.15	2.82	3.28	2.42	2.29
Return On Equity %	10.99	6.68	8.21	1.91	2.63
Return on Common Equity	11.33	6.68	8.22	1.94	2.67
Margin Analysis
Gross Profit Margin %	17.64	16.77	17.36	14.1	14.57
SG&A Margin	9.07	12.16	10.55	9.3	10.37
EBITDA Margin %	10.17	6.8	8.61	8.51	8.72
EBITA Margin %	8.1	4.02	5.51	4.01	4.03
EBIT Margin %	7.98	3.89	5.35	3.87	3.88
Income From Continuing Operations Margin %	4.9	3.34	4.8	1.09	1.51
Net Income Margin %	5	3.34	4.8	1.1	1.54
Net Avail. For Common Margin %	5	3.34	4.8	1.1	1.54
Normalized Net Income Margin	4.41	1.86	2.82	1.34	1.11
Levered Free Cash Flow Margin	-8.63	-9.81	-5.33	-7.77	3.05
Unlevered Free Cash Flow Margin	-7.93	-9.08	-4.53	-6.46	4.45
Asset Turnover
Asset Turnover	1.24	1.01	0.86	0.9	0.86
Fixed Assets Turnover	3.72	2.51	2.07	2.27	2.37
Receivables Turnover (Average Receivables)	4.23	3.81	3.42	3.51	3.06
Inventory Turnover (Average Inventory)	12.4	9.48	6.98	6.38	5.67
Short Term Liquidity
Current Ratio	2.19	1.52	1.84	1.79	1.81
Quick Ratio	1.74	1.14	1.39	1.28	1.39
Operating Cash Flow to Current Liabilities	0.28	-0.01	0.16	-0.03	0.18
Days Sales Outstanding (Average Receivables)	86.3	95.89	106.6	104.42	119.19
Days Outstanding Inventory (Average Inventory)	29.43	38.51	52.26	57.35	64.39
Average Days Payable Outstanding	27.44	30.76	34.32	26.33	27.9
Cash Conversion Cycle (Average Days)	88.3	103.64	124.53	135.43	155.67
Long Term Solvency
Total Debt/Equity	63.95	81.06	69.2	82.08	84.87
Total Debt / Total Capital	39.01	44.77	40.9	45.08	45.91
LT Debt/Equity	43.15	40.04	37.32	38.83	37.04
Long-Term Debt / Total Capital	26.32	22.11	22.06	21.33	20.04
Total Liabilities / Total Assets	47.05	51.82	47.52	50.24	50.57
EBIT / Interest Expense	7.16	3.36	4.21	1.85	1.74
EBITDA / Interest Expense	9.13	5.87	6.78	4.08	3.91
(EBITDA - Capex) / Interest Expense	-3.99	-2.44	-0.01	2.42	3.14
Total Debt / EBITDA	3.02	6.09	5.16	5.47	5.64
Net Debt / EBITDA	1.79	4.6	3.16	3.83	3.55
Total Debt / (EBITDA - Capex)	-6.93	-14.64	-2.82K	9.22	7.01
Net Debt / (EBITDA - Capex)	-4.1	-11.05	-1.73K	6.45	4.42
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	42.75	-1.45	-3.04	12.66	-1.59
Gross Profit, 1 Yr. Growth %	20.31	-10.05	4.69	-8.5	1.69
EBITDA, 1 Yr. Growth %	32.82	-34.12	22.71	4.19	0.78
EBITA, 1 Yr. Growth %	36.68	-51.05	32.7	-25.97	-1.06
EBIT, 1 Yr. Growth %	37.38	-51.97	33.32	-26.66	-1.27
Earnings From Cont. Operations, 1 Yr. Growth %	7.67	-32.85	39.48	-74.53	37.03
Net Income, 1 Yr. Growth %	8.8	-34.17	39.51	-74.12	37.4
Normalized Net Income, 1 Yr. Growth %	38.38	-58.4	47.01	-52.84	-18.15
Diluted EPS Before Extra, 1 Yr. Growth %	5.41	-33.33	38.46	-72.22	30
Accounts Receivable, 1 Yr. Growth %	6.72	12.66	3.25	16.87	8.92
Inventory, 1 Yr. Growth %	-7.57	71.28	6.92	48.02	-15.38
Net Property, Plant and Equip., 1 Yr. Growth %	84.43	25.42	10.98	-4.37	-7.39
Total Assets, 1 Yr. Growth %	28.19	15	11.96	5.14	1.65
Tangible Book Value, 1 Yr. Growth %	24.45	2.17	24.9	-0.05	1.29
Common Equity, 1 Yr. Growth %	19.87	4.64	21.95	-0.29	1.58
Cash From Operations, 1 Yr. Growth %	121.27	-107.76	-1.22K	-124.12	-673.33
Capital Expenditures, 1 Yr. Growth %	102.41	-35.08	-13.05	-54.79	-51.42
Levered Free Cash Flow, 1 Yr. Growth %	214.37	12.01	-47.33	76.7	-138.67
Unlevered Free Cash Flow, 1 Yr. Growth %	237.56	12.85	-51.61	75.1	-167.75
Dividend Per Share, 1 Yr. Growth %	0	-	-	-50	100
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	23.76	18.61	-2.24	4.52	5.29
Gross Profit, 2 Yr. CAGR %	6.15	6.19	-4.99	-2.13	-3.54
EBITDA, 2 Yr. CAGR %	19.15	-6.46	-10.09	16.94	2.47
EBITA, 2 Yr. CAGR %	20.43	-18.21	-19.4	4.36	-14.42
EBIT, 2 Yr. CAGR %	20.53	-18.77	-19.98	4.27	-14.91
Earnings From Cont. Operations, 2 Yr. CAGR %	10.53	-14.97	-3.22	-40.4	-40.92
Net Income, 2 Yr. CAGR %	11.63	-15.37	-4.16	-39.91	-40.37
Normalized Net Income, 2 Yr. CAGR %	21.2	-24.13	-21.8	-11.39	-37.87
Diluted EPS Before Extra, 2 Yr. CAGR %	10.4	-16.17	-3.92	-37.98	-39.91
Accounts Receivable, 2 Yr. CAGR %	-1.43	9.65	7.85	9.85	12.83
Inventory, 2 Yr. CAGR %	26.41	25.82	35.33	25.81	11.92
Net Property, Plant and Equip., 2 Yr. CAGR %	50.45	52.09	17.98	3.02	-5.89
Total Assets, 2 Yr. CAGR %	27.05	21.41	13.47	8.5	3.1
Tangible Book Value, 2 Yr. CAGR %	15.86	12.76	12.96	11.73	0.03
Common Equity, 2 Yr. CAGR %	15.08	11.99	12.96	10.27	0.1
Cash From Operations, 2 Yr. CAGR %	-4.69	-58.57	-6.97	64.07	17.6
Capital Expenditures, 2 Yr. CAGR %	124.58	14.63	-24.87	-37.31	-53.14
Levered Free Cash Flow, 2 Yr. CAGR %	53.07	87.65	-23.19	-6.98	-17.34
Unlevered Free Cash Flow, 2 Yr. CAGR %	39.77	95.17	-26.11	-11.84	8.92
Dividend Per Share, 2 Yr. CAGR %	9.54	-	-8.71	-	0
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	8.74	14.71	10.91	2.49	2.44
Gross Profit, 3 Yr. CAGR %	0.85	1.83	4.2	-6.18	-0.87
EBITDA, 3 Yr. CAGR %	7.07	-2.21	2.4	-3.42	11.28
EBITA, 3 Yr. CAGR %	6.72	-10.79	-3.89	-18.91	2.52
EBIT, 3 Yr. CAGR %	6.68	-11.31	-4.18	-19.47	2.39
Earnings From Cont. Operations, 3 Yr. CAGR %	0.32	-6.39	0.28	-37.98	-21.33
Net Income, 3 Yr. CAGR %	0.98	-6.39	-0.02	-38.05	-20.84
Normalized Net Income, 3 Yr. CAGR %	6.56	-15.14	-5.41	-31.14	-13.7
Diluted EPS Before Extra, 3 Yr. CAGR %	0	-6.69	-0.91	-36.47	-20.63
Accounts Receivable, 3 Yr. CAGR %	-0.66	3.05	7.47	10.78	9.54
Inventory, 3 Yr. CAGR %	3.8	39.88	19.18	39.43	10.23
Net Property, Plant and Equip., 3 Yr. CAGR %	42.45	41.59	36.92	10	-0.57
Total Assets, 3 Yr. CAGR %	16.91	22.9	18.18	10.62	5.97
Tangible Book Value, 3 Yr. CAGR %	15.26	11.1	16.67	8.45	7.71
Common Equity, 3 Yr. CAGR %	14.13	11.49	15.22	8.36	6.91
Cash From Operations, 3 Yr. CAGR %	21.48	-58.7	24.19	-40.68	148.98
Capital Expenditures, 3 Yr. CAGR %	148.28	48.49	4.54	-36.57	-42.42
Levered Free Cash Flow, 3 Yr. CAGR %	50.38	37.94	22.86	-1.04	-30.58
Unlevered Free Cash Flow, 3 Yr. CAGR %	38.46	30.15	22.61	-4.28	-19.25
Dividend Per Share, 3 Yr. CAGR %	9.7	-	-5.9	-25.31	-
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	16.3	10.82	4.2	10.52	8.63
Gross Profit, 5 Yr. CAGR %	7.93	9.59	-0.72	-0.62	1.03
EBITDA, 5 Yr. CAGR %	12.72	4.3	-0.15	5.04	3.82
EBITA, 5 Yr. CAGR %	15.72	1.2	-4.62	-5.01	-6.33
EBIT, 5 Yr. CAGR %	15.93	1.02	-4.91	-5.38	-6.67
Earnings From Cont. Operations, 5 Yr. CAGR %	44.37	14.83	-1.11	-21.85	-18.85
Net Income, 5 Yr. CAGR %	44.94	14.83	-1.11	-21.6	-18.69
Normalized Net Income, 5 Yr. CAGR %	38.47	0.4	-5.84	-13.66	-18.04
Diluted EPS Before Extra, 5 Yr. CAGR %	43.54	13.77	-1.59	-20.76	-18.88
Accounts Receivable, 5 Yr. CAGR %	8.78	5.37	2.66	5.72	9.58
Inventory, 5 Yr. CAGR %	7.54	19.64	15.42	34.07	16.22
Net Property, Plant and Equip., 5 Yr. CAGR %	20.35	27.68	32.1	24.68	17.85
Total Assets, 5 Yr. CAGR %	14.52	17.2	15.52	16.92	11.9
Tangible Book Value, 5 Yr. CAGR %	14.99	13.59	14.34	11.35	9.7
Common Equity, 5 Yr. CAGR %	13.37	12.86	13.66	11	8.91
Cash From Operations, 5 Yr. CAGR %	-23.4	-32.86	9.18	-28.29	21.51
Capital Expenditures, 5 Yr. CAGR %	98.81	50.36	53.92	5.18	-24.16
Levered Free Cash Flow, 5 Yr. CAGR %	-6.67	117.14	14.94	17.83	3.34
Unlevered Free Cash Flow, 5 Yr. CAGR %	-10.34	106.09	7.71	11.37	14.94
Dividend Per Share, 5 Yr. CAGR %	67.51	-	1.93	-12.94	-3.58